• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Public Health . Effectiveness of influenza vaccination against coronavirus disease (COVID)-19 outcomes in hospitalized individuals in Brazil: an epi

tetano

Editor, Senior Moderator
Public Health


. 2023 Oct 30:225:8-11.
doi: 10.1016/j.puhe.2023.09.015. Online ahead of print. Effectiveness of influenza vaccination against coronavirus disease (COVID)-19 outcomes in hospitalized individuals in Brazil: an epidemiological study

N M S Sansone[SUP] 1 [/SUP], M N Boschiero[SUP] 2 [/SUP], M Darrieux[SUP] 3 [/SUP], F A L Marson[SUP] 4 [/SUP]



Affiliations
Abstract

Objectives: This study aimed to evaluate the impact of the flu vaccination on the mortality of hospitalized individuals with coronavirus disease (COVID)-19 in Brazil.
Study design: A retrospective cohort study was conducted based on epidemiological data released by the Brazilian Ministry of Health.
Methods: An observational study was performed using epidemiological data available at OpenDataSUS. The primary outcome was death-the study period comprised December 29, 2019, to April 6, 2023. The odds ratio with a 95% confidence interval (OR; 95% CI) was calculated to evaluate the association between the epidemiological markers, including the vaccination status against influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the outcome using a multivariable analysis.
Results: The study comprised 791,891 hospitalized individuals with COVID-19. In the study, male sex, older age, living in rural areas, and race (Black and Indigenous peoples), as well as the presence of clinical signs, comorbidities (except the presence of asthma, which was protective), need for intensive care unit, and invasive mechanical ventilation, were associated with a higher chance of death; the vaccination was protective. Among patients with COVID-19, the individuals who received vaccination against influenza [N = 138,564; OR = 0.754 (95% CI = 0.742-0.766)], SARS-CoV-2 [N = 114,628; OR = 0.630 (95% CI = 0.620-0.641)], or both vaccines [N = 55,616; OR = 0.544 (95% CI = 0.531-0.556)], when compared to the individuals who received no vaccination (N = 483,083), had a lower chance of death.
Conclusions: The flu vaccination might be responsible for decreased mortality in hospitalized patients with COVID-19 in Brazil.

Keywords: Brazil; COVID-19; Immunity; Influenza; Pandemic; Vaccination.

 
Back
Top Bottom